CVKD vs FAST · $20.2M cap vs P/E 43, rev $4.59B
Cadrenal Therapeutics, Inc. Common Stock (CVKD) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
CVKD does not have a complete income-statement cache yet.
Latest reported FAST revenue for 2026-06-30 was $4.59B. Net income was $722.6M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
CVKD currently screens at market cap $20.2M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the CVKD and FAST stock pages for the full models.
Not investment advice.